CHRISTIAN O HENRY
CIK 1263805 · See Remarks · last filed 2026-06-15
CHRISTIAN O HENRY is a corporate insider who has filed 201 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for DNA, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$99.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8.79M
5
201
-$99.11M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNA | Director | 34,310 | $7.70 | $264.2K | -$219.8K | 3 | 2026-06-15 |
| PACB | See Remarks | 3,581,813 | $1.39 | $4.98M | -$9.45M | 27 | 2026-03-04 |
| WVE | Director | 27,700 | $5.89 | $163.2K | -$1.56M | 12 | 2025-12-10 |
| Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Director | 1,339,641 | $0.01 | $8.4K | -$20.53M | 20 | 2024-06-14 |
| ILMN | EVP & Chief Commercial Officer | 17,531 | $192.98 | $3.38M | -$67.35M | 115 | 2017-01-31 |
Recent Filings
201 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | DNA | Grant (A) | — | $0 | EDGAR |
| 2026-03-04 | PACB | Sell (S) | −12,497 | -$18.9K | EDGAR |
| 2026-03-03 | PACB | Notice (144) | −12,497 | -$18.9K | EDGAR |
| 2026-03-03 | PACB | Grant (A) | +920,810 | $0 | EDGAR |
| 2026-02-19 | PACB | Sell (S) | −472,667 | -$752.4K | EDGAR |
| 2026-02-17 | PACB | Notice (144) | −606,312 | -$955.5K | EDGAR |
| 2025-12-10 | WVE | Mixed | −6,445 | -$928.5K | EDGAR |
| 2025-12-08 | WVE | Notice (144) | −93,445 | -$1.73M | EDGAR |
| 2025-09-10 | DNA | Sell (S) | −20,000 | -$219.8K | EDGAR |
| 2025-09-09 | DNA | Notice (144) | −10,000 | -$110.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.